The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment

Alzheimer's and Dementia

Volumn 11, Issue 12, 2015, Pages 1510-1519

  Tosto, Giuseppe ^a   Zimmerman, Molly E ^b,c   Hamilton, Jamie L ^a   Carmichael, Owen T ^d   Brickman, Adam M ^a  

^a Columbia University ^*  (United States)

^b FORDHAM UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Alzheimer's disease; CSF tau; Mild cognitive impairment; White matter hyperintensities

Indexed keywords

TAU PROTEIN; AMYLOID BETA PROTEIN; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBROSPINAL FLUID; ENTORHINAL CORTEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER; ATROPHY; COGNITIVE DEFECT; DISEASE COURSE; METABOLISM; MIDDLE AGED; MYELINATED NERVE; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; ENTORHINAL CORTEX; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PEPTIDE FRAGMENTS; TAU PROTEINS; WHITE MATTER;

EID: 84952630634     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.05.014     Document Type: Article

References (45)

1. D.E. Barnes, and K. Yaffe The projected effect of risk factor reduction on Alzheimer's disease prevalence Lancet Neurol 10 2011 819 828
2. P.B. Gorelick Cerebrovascular disease in African Americans Stroke 29 1998 2656 2664
3. E.P. Helzner, J.A. Luchsinger, N. Scarmeas, S. Cosentino, A.M. Brickman, M.M. Glymour, and et al. Contribution of vascular risk factors to the progression in Alzheimer disease Arch Neurol 66 2009 343 348
4. M. Kivipelto, E.-L. Helkala, M.P. Laakso, T. Hänninen, M. Hallikainen, K. Alhainen, and et al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study BMJ 322 2001 1447 1451
5. J. Luchsinger, A. Brickman, C. Reitz, S. Cho, N. Schupf, J. Manly, and et al. Subclinical cerebrovascular disease in mild cognitive impairment Neurology 73 2009 450 456
6. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, A.M. Fagan, and et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
7. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, N.C. Fox, and et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
8. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., C.H. Kawas, and et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
9. W. Wen, and P. Sachdev The topography of white matter hyperintensities on brain MRI in healthy 60-to 64-year-old individuals Neuroimage 22 2004 144 154
10. A.M. Brickman, K.L. Siedlecki, J. Muraskin, J.J. Manly, J.A. Luchsinger, L.-K. Yeung, and et al. White matter hyperintensities and cognition: Testing the reserve hypothesis Neurobiol Aging 32 2011 1588 1598
11. G. Tosto, M.E. Zimmerman, O.T. Carmichael, A.M. Brickman Initiative ADN, others Predicting aggressive decline in mild cognitive impairment: The importance of white matter hyperintensities JAMA Neurol 71 2014 872 877
12. A.M. Brickman, L.S. Honig, N. Scarmeas, O. Tatarina, L. Sanders, M.S. Albert, and et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease Arch Neurol 65 2008 1202 1208
13. F.A. Provenzano, J. Muraskin, G. Tosto, A. Narkhede, B.T. Wasserman, E.Y. Griffith, and et al. White matter hyperintensities and cerebral amyloidosis: Necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol 70 2013 455 461
14. A.M. Brickman, F.A. Provenzano, J. Muraskin, J.J. Manly, S. Blum, Z. Apa, and et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community Arch Neurol 69 2012 1621 1627
15. A.M. Brickman, L.B. Zahodne, V.A. Guzman, A. Narkhede, I.B. Meier, E.Y. Griffith, and et al. Reconsidering harbingers of dementia: Progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence Neurobiol Aging 36 2014 27 32
16. A.M. Brickman, N. Schupf, and J.J. Manly Does APOE-ε4 confer risk for Alzheimer's disease through regionally distributed white matter hyperintensities? Alzheimers Dement 10 2014 619 629
17. K. Chalmers, G. Wilcock, and S. Love Contributors to white matter damage in the frontal lobe in Alzheimer's disease Neuropathol Appl Neurobiol 31 2005 623 631
18. T.J. Haight, S.M. Landau, O. Carmichael, C. Schwarz, C. DeCarli, and W.J. Jagust Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism JAMA Neurol 70 2013 1039 1045
19. T. Polvikoski, E. van Straaten, F. Barkhof, R. Sulkava, H. Aronen, L. Niinist, and et al. Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old Neurology 75 2010 2071 2078
20. J. Hertze, S. Palmqvist, L. Minthon, and O. Hansson Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease Dement Geriatr Cogn Dis Extra 3 2013 113 122
21. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, M.W. Weiner, and et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
22. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, P.S. Aisen, and et al. Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
23. B.T. Hyman, and J.Q. Trojanowski Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease J Neuropathol Exp Neurol 56 1997 1095 1097
24. V.C. Hachinski, L.D. Iliff, E. Zilhka, G.H. Du Boulay, V.L. McAllister, J. Marshall, and et al. Cerebral blood flow in dementia Arch Neurol 32 1975 632 637
25. J.C. Morris The Clinical Dementia Rating (CDR): Current version and scoring rules Neurology 43 1993 2412 2414
26. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
27. J.A. Yesavage, T. Brink, T.L. Rose, O. Lum, V. Huang, M. Adey, and et al. Development and validation of a geriatric depression screening scale: A preliminary report J Psychiatr Res 17 1983 37 49
28. M.W. Weiner, P.S. Aisen, C.R. Jack Jr., W.J. Jagust, J.Q. Trojanowski, L. Shaw, and et al. The Alzheimer's disease neuroimaging initiative: Progress report and future plans Alzheimers Dement 6 2010 202 211
29. C.R. Jack, M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, D. Harvey, and et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods J Magn Reson Imaging 27 2008 685 691
30. C. Schwarz, E. Fletcher, C. DeCarli, and O. Carmichael Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR Inf Process Med Imaging 21 2009 239 251
31. A.C. Birdsill, R.L. Koscik, E.M. Jonaitis, S.C. Johnson, O.C. Okonkwo, B.P. Hermann, and et al. Regional white matter hyperintensities: Aging, Alzheimer's disease risk, and cognitive function Neurobiol Aging 35 2014 769 776
32. R. Wolz, V. Julkunen, J. Koikkalainen, E. Niskanen, D.P. Zhang, D. Rueckert, and et al. Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease PLoS One 6 2011 e25446
33. C. DeCarli, D. Murphy, D. Teichberg, G. Campbell, and G. Sobering Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity J Magn Reson Imaging 6 1996 519 528
34. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, R.C. Petersen, and et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
35. B.T. Wyman, D.J. Harvey, K. Crawford, M.A. Bernstein, O. Carmichael, P.E. Cole, and et al. Standardization of analysis sets for reporting results from ADNI MRI data Alzheimers Dement 9 2013 332 337
36. K.-Y. Liang, and S.L. Zeger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22
37. E. Bruner, and H.I. Jacobs Alzheimer's disease: The downside of a highly evolved parietal lobe? J Alzheimers Dis 35 2013 227 240
38. H.I. Jacobs, M.P. Van Boxtel, J. Jolles, F.R. Verhey, and H. Uylings Parietal cortex matters in Alzheimer's disease: An overview of structural, functional and metabolic findings Neurosci Biobehav Rev 36 2012 297 309
39. K. Ishii, H. Sasaki, A.K. Kono, N. Miyamoto, T. Fukuda, and E. Mori Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies Eur J Nucl Med Mol Imaging 32 2005 959 963
40. A.M. Brickman Contemplating Alzheimer's disease and the contribution of white matter hyperintensities Curr Neurol Neurosci Rep 13 2013 1 9
41. F. Fazekas, R. Kleinert, H. Offenbacher, R. Schmidt, G. Kleinert, F. Payer, and et al. Pathologic correlates of incidental MRI white matter signal hyperintensities Neurology 43 1993 1683 1689
42. D. Erten-Lyons, R. Woltjer, J. Kaye, N. Mattek, H.H. Dodge, S. Green, and et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age Neurology 81 2013 977 983
43. W.J. Jagust, L. Zheng, D.J. Harvey, W.J. Mack, H.V. Vinters, M.W. Weiner, and et al. Neuropathological basis of magnetic resonance images in aging and dementia Ann Neurol 63 2008 72 80
44. R.Y. Lo, W.J. Jagust, M. Weiner, P. Aisen, R. Petersen, C.R. Jack, and et al. Vascular burden and Alzheimer disease pathologic progression Neurology 79 2012 1349 1355
45. E. Richard, A.A. Gouw, P. Scheltens, and W.A. van Gool Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI the Evaluation of Vascular Care in Alzheimer's Disease (EVA) Study Stroke 41 2010 554 556